🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open-label multicentre, randomised study to assess the ...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2015-01
Trial ID
NCT02299089
Treatments Being Tested
This randomized phase III trial studies octreotide acetate and recombinant ...
Status
Active Not Recruiting
Location
Providence Hospital
Start Date
2007-12-01
Trial ID
NCT00569127
Treatments Being Tested
This phase I trial studies the side effects and best dose of cixutumumab wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01204476
Treatments Being Tested
An observational time and motion study in a clinical oncology setting is ut...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2017-04-12
Trial ID
NCT03017690
The investigators hypothesize that octreotide LAR (Long Acting Release) saf...
Status
Completed
Location
Virginia Commonwealth University Health System
Start Date
2013-02
Trial ID
NCT01707225
Treatments Being Tested
The hepatocellular carcinoma (HCC) represents more than 5% of all human mal...
Status
Completed
Location
D. Cotugno Hospital
Start Date
2007-04
Trial ID
NCT00495846
Treatments Being Tested
This study is in patients with at least moderate obesity (Body Mass Index \...
Status
Completed
Location
New Orleans Center for Clinical Research
Start Date
2002-01
Trial ID
NCT00094146
Treatments Being Tested
This study will evaluate the efficacy and safety of pasireotide LAR 40 and ...
Status
Completed
Location
University of Michigan
Start Date
2010-07-19
Trial ID
NCT01137682
Treatments Being Tested
Currently there is an ongoing clinical trial for patients with chemotherapy...
Status
Completed
Location
Kenmar Research Institute
Start Date
2002-12
Trial ID
NCT00050635
Treatments Being Tested
The purpose of this study was to evaluate whether everolimus 10 mg / day ad...
Status
Completed
Location
University of Arizona / Arizona Cancer Center Deptof Uof A/Arizona Cancer(2)
Start Date
2006-12
Trial ID
NCT00412061
Treatments Being Tested